|
|
|
Friday, August 15, 2008
Genentech Asks Roche to Pay Up
In one of the more friendly spurnings of a buyout offer in recent months, Genentech (NYSE: DNA) yesterday called Roche's $89-per-share buyout offer too low, and very nicely implied that Roche should up its bid.
Please click here for more details.
|
|
